AngioDynamics, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K, dated October 10, 2018, details the results of the Annual Meeting of Shareholders held on that date. The filing covers the election of directors, ratification of auditors, and approval of executive compensation and equity plans.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance voting outcomes rather than financial performance.
Material Changes and Voting Results
Shareholders approved all five proposals presented at the meeting:
- Director Election: Wesley E. Johnson, Jr. was elected as a Class III director with 31,013,730 votes for, 1,248,628 withheld, and 1,847,607 broker non-votes.
- Auditor Ratification: Deloitte & Touche LLP was ratified as the independent registered public accounting firm for the fiscal year ending May 31, 2019, with 33,990,100 votes for approval.
- Executive Compensation: The advisory proposal to approve executive compensation was approved with 30,845,912 votes for.
- Stock and Incentive Award Plan: The amended 2004 plan was approved with 27,786,715 votes for.
- Employee Stock Purchase Program: The amended program was approved with 31,794,204 votes for.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items.
Key Facts for Investor Verification
- Wesley E. Johnson, Jr. serves as a Class III director until the 2021 Annual Meeting.
- Deloitte & Touche LLP is confirmed as the auditor for the fiscal year ending May 31, 2019.
- Significant shareholder support was demonstrated for executive compensation and equity incentive plans.
- Broker non-votes totaled 1,847,607 for the director election and equity plan proposals.